SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

Pantone Café/REX/Shutterstock

162

Danaher

DHR

The global diversified conglomerate has a variety of businesses–including water treatment supplies, testing and measuring devices, and dental office equipment.

Looking for leads, investment insights, or competitive intelligence?

CEO

Thomas P. Joyce Jr.

CEO Title

President, Chief Executive Officer & Director

Sector

Health Care

Industry

Medical Products and Equipment

HQ Location

Washington

Years on Fortune 500 List

20

Employees

67,000

Spun off Fortive (2017 rank: 420), July 2, 2016.
Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$18,330-7.9%
Profits ($M)$2,492.1-2.4%
Assets ($M)$46,649
Total Stockholder Equity ($M)$26,358
Market Value — as of March 29, 2018 ($M)$68,385
Profit Ratios
Profit as % of Revenues13.6%
Profits as % of Assets5.3%
Profits as % of Stockholder Equity9.5%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)3.53
EPS % Change (from 2016)-3.3%
EPS % Change (5 year annual rate)1.0%
EPS % Change (10 year annual rate)5.4%
Total Return
Total Return to Investors (2017)20.0%
Total Return to Investors (5 year, annualized)17.2%
Total Return to Investors (10 year, annualized)11.0%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Danaher

Disruptive diagnostics firm Theranos gets boost from FDA

The agency clears the company's test platform and herpes test—a possible prelude to other approvals.

Read More →
Activist investors love spin-offs. Here’s why you should, too

The stocks spawned by corporate breakups often have rocky debuts, but many bounce back and outperform the market.

Read More →
Booz & Company CEO: You survived the financial crisis. Now what?

As the economy recovers, here are five ways to steer your company on the path toward long-term growth

Read More →